Summary
A SEVERE shortage of a critical anti-rejection drug for organ transplant patients is triggering what the Kidney Recipients Support Group of Trinidad and Tobago has described as a national health
Source: Trinidad and Tobago Express
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
